Rethinking drug discovery using machine learning

insitro will integrate cutting-edge machine learning techniques with the ground-breaking innovations that have occurred in life sciences that enable the creation of the large, high-quality data sets. The company will collect and use a range of very large data sets to train ML models to help address key problems in the drug discovery and development process.

Year Invested: 2018

Associated Team Members

Alexis Borisy